SCHEMBL32665367

SCHEMBL32665367

Cc1ccc(-c2nnc3ccc(N4CCC(C(=O)NCCN5CCCC5)CC4)nn23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
TSHR P16473 2/20 0.52
RECQL P46063 2/20 0.52
HSD17B10 Q99714 4/20 0.47
PIM1 P11309 1/20 0.47
KDM4E B2RXH2 4/20 0.46
GAA P10253 2/20 0.46
POLB P06746 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
APAF1 O14727 1/20 0.46
DPP4 P27487 4/20 0.46
HPGD P15428 3/20 0.45
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALOX15 P16050 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665534 0.92 HSD17B10 (0.46) ALDH1A1TSHRRECQLHSD17B10PIM1
SCHEMBL32665421 0.86 ALDH1A1 (0.46) ALDH1A1TSHRHSD17B10PIM1KDM4E
SCHEMBL32664898 0.85 MAPT (0.49) ALDH1A1TSHRHSD17B10PIM1KDM4E
SCHEMBL32665452 0.84 ALDH1A1 (0.47) ALDH1A1TSHRHSD17B10PIM1KDM4E
SCHEMBL32665080 0.84 NPC1 (0.49) ALDH1A1TSHRPIM1KDM4EGAA
SCHEMBL32665554 0.83 ALDH1A1 (0.45) ALDH1A1TSHRHSD17B10PIM1KDM4E
SCHEMBL32665009 0.83 DPP4 (0.57) ALDH1A1TSHRHSD17B10KDM4EGAA
SCHEMBL32665350 0.81 TP53 (0.46) ALDH1A1TSHRHSD17B10KDM4EGAA
SCHEMBL32664943 0.80 ALDH1A1 (0.53) ALDH1A1TSHRHSD17B10PIM1KDM4E
SCHEMBL32665398 0.78 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10PIM1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS UNIV MINNESOTA (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS NR5A1, CYP17A1, CNR1 ALDH1A1 663/4885TSHR 864/4885RECQL 2749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.